Cargando…

POLD4 Promotes Glioma Cell Proliferation and Suppressive Immune Microenvironment: A Pan-Cancer Analysis Integrated with Experimental Validation

POLD4 plays a crucial part in the complex machinery of DNA replication and repair as a vital component of the DNA polymerase delta complex. In this research, we obtained original information from various publicly available databases. Using a blend of R programming and internet resources, we initiate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Cheng, Fan, Fei, Xu, Weiming, Jiang, Xiaobing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530695/ https://www.ncbi.nlm.nih.gov/pubmed/37762224 http://dx.doi.org/10.3390/ijms241813919

Ejemplares similares

An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer
por: Cong, Fengyun, et al.
Publicado: (2022)

Roles of human POLD1 and POLD3 in genome stability
por: Tumini, Emanuela, et al.
Publicado: (2016)

Immune‐related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients
por: Yu, Hao, et al.
Publicado: (2022)

Overexpression of TREM1 is Associated with the Immune-Suppressive Microenvironment and Unfavorable Prognosis in Pan-Cancer
por: Zhou, Xinwei, et al.
Publicado: (2023)

The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
por: Mi, Yajing, et al.
Publicado: (2020)

DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC
por: Wang, Yejinpeng, et al.
Publicado: (2023)

POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Tian, Junjie, et al.
Publicado: (2023)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

Role of POLE and POLD1 in familial cancer
por: Mur, Pilar, et al.
Publicado: (2020)

POLE/POLD1 mutation and tumor immunotherapy
por: Ma, Xiaoting, et al.
Publicado: (2022)

A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma
por: Zheng, Jianglin, et al.
Publicado: (2022)

Pold3 is required for genomic stability and telomere integrity in embryonic stem cells and meiosis
por: Zhou, Zhongcheng, et al.
Publicado: (2018)

POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
por: Chen, Yan‐Xing, et al.
Publicado: (2021)

CTCF Mediates Replicative Senescence Through POLD1
por: Hou, Yuli, et al.
Publicado: (2021)

Prospects of POLD1 in Human Cancers: A Review
por: Gola, Michał, et al.
Publicado: (2023)

POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation
por: Zhang, Zhen
Publicado: (2022)

Immune Characteristics of LYN in Tumor Microenvironment of Gliomas
por: Jiang, Chonghua, et al.
Publicado: (2022)

Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families
por: Weber, Christine A. M., et al.
Publicado: (2023)

Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma
por: He, Ya, et al.
Publicado: (2022)

The role of angiogenic growth factors in the immune microenvironment of glioma
por: Ge, Zhengmao, et al.
Publicado: (2023)

Immune response in glioma’s microenvironment
por: Chen, Houminji, et al.
Publicado: (2021)

A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
por: Tang, Hui, et al.
Publicado: (2022)

Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas
por: Gieryng, Anna, et al.
Publicado: (2017)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

In silico Experimentation of Glioma Microenvironment Development and Anti-tumor Therapy
por: Wu, Yu, et al.
Publicado: (2012)

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment
por: Xu, Wen-Xiu, et al.
Publicado: (2020)

Longitudinal evolution of the immune suppressive glioma microenvironment in different synchronous lesions during treatment
por: Mandruzzato, Susanna, et al.
Publicado: (2020)

PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma
por: Wang, Jinxiang, et al.
Publicado: (2023)

Radiomics for characterization of the glioma immune microenvironment
por: Khalili, Nastaran, et al.
Publicado: (2023)

An R-loop-initiated CSB–RAD52–POLD3 pathway suppresses ROS-induced telomeric DNA breaks
por: Tan, Jun, et al.
Publicado: (2020)

Elevated expression of POLD1 is associated with poor prognosis in breast cancer
por: Qin, Qinghong, et al.
Publicado: (2018)

Rapid genome editing by CRISPR-Cas9-POLD3 fusion
por: Reint, Ganna, et al.
Publicado: (2021)

Scrutinizing Deleterious Nonsynonymous SNPs and Their Effect on Human POLD1 Gene
por: Bappy, Md. Nazmul Islam, et al.
Publicado: (2022)

Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1
por: Mur, Pilar, et al.
Publicado: (2023)

Ferritin light chain promotes the reprogramming of glioma immune microenvironment and facilitates glioma progression
por: Li, Hongjiang, et al.
Publicado: (2023)

A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival
por: Turan, Tolga, et al.
Publicado: (2020)

LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification
por: Zhou, Yujie, et al.
Publicado: (2022)

Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression
por: Liang, Zhi-Jie, et al.
Publicado: (2021)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
por: He, Songjiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v6bubeq2qa5rbkei6hesulor97